
Sign up to save your podcasts
Or


MITO Meeting: MONTHLY INTERNATIONAL TELECONFERENCE OUTREACH
Join us this month with Dr. Alex Flores, Chief of Pediatric Gastroenterology and Nutrition, Floating Hospital for Children at Tufts Medical Center, and an Associate Professor at Tufts University School of Medicine in Boston, MA.
Dr. Flores works closely with Dr. Mark Korson to support the special group of patients with mitochondrial disease and a dominant GI dysfunction as part of their disease symptoms.
Dr. Flores is board certified in Pediatric Gastroenterology and Pediatrics. In addition to developing the LAPEG procedure, Dr. Flores' specialties include GI motility disorders, and general pediatric gastroenterology.
Dr. Flores will share his perspective on the most common GI issues for children and adults affected by mitochondrial disease.
This MitoAction podcast summary introduces Dr. Alex Flores, a pediatric gastroenterologist at Tufts Floating Hospital for Children. He discusses the specific issues, causes, symptoms, and solutions for children with GI motility problems. This podcast summary also includes questions posed by listeners.
Join us this month with Dr. Fran Kendall from Emory University Department of Human Genetics as we dig deeper into confusion surrounding two components of the “Mito Cocktail”: Coenzyme Q10 and Creatine.
A long-time advocate and clinician for mitochondrial disease patients, Dr. Kendall began the Mitochondrial Disorders Program at Boston Children’s Hospital 18 years ago. Since that time, she has been involved in direct patient care as well as diagnostics and biochemical genetics research and currently follows patients through her Atlanta practice.
Exclusive Interview with Dr. Guy Miller, CEO of Edison Pharma.
Is there hope for a cure for Mitochondrial Disease? Perhaps the answer is closer than we thought.
On July 15, 2008 Edison Pharma and partner Penwest Pharmaceuticals announced that A0001, an “improved” variant of Coenzyme Q10 (CoQ10), has entered Phase 1 clinical development with healthy volunteers. Edison predicts trials in patients with inherited mitochondrial disease will begin in 2009.
MitoAction welcomed Dr. Irina Anselm, pediatric neurologist and head of the mitochondrial disease clinic at Children’s Hospital Boston to discuss the topic of pain for patients with mitochondrial disease at our monthly international teleconference.
The MitoAction committee chairs met by conference call to discuss the exciting ideas and projects ahead for 2008.
From the publisher's feed